Tag: healthcare
-
Omega Healthcare gets dividend safety rating downgrade from Simply Safe Dividends
The nursing home REIT is suffering from a host of issues related to the pandemic. One of its operators reported it would no longer be able to pay rent due to lack of occupancy and rising labor costs. Vaccine mandates aren’t making things easier either with only about 61% of the nation’s nursing home staff…
-
Early data promising for Johnson & Johnson booster shot
Johnson & Johnson is reporting those receiving a booster shot after 6 months show a 9 times increase in antibody levels. The data isn’t peer reviewed yet so it’s early days I guess. J&J said researchers found antibody levels increased ninefold among people who received a second dose of its vaccine, compared with one month…
-
Johnson & Johnson COVID-19 vaccine study shows strong efficacy against Delta variant
In some good COVID-19 news, it looks like the single dose Johnson & Johnson vaccine is the dark horse in the vaccine race. It’s showing higher efficacy over a longer period as well as higher efficacy against the dreaded Delta variant. A new study from South Africa, called Sisonke, has shown Johnson & Johnson’s vaccine…
-
One step forward two steps back
Chasing the Yield – August 23, 2021 Episode 18 Value 4 Value podcastingListen to this podcast on PodFriend News https://www.chasingtheyield.com/2021/08/18/target-sales-up-8-9-year-over-year/ https://www.chasingtheyield.com/2021/08/18/main-street-capital-announces-38-5-million-in-investments/ https://www.chasingtheyield.com/2021/08/19/jjs-ceo-announces-hes-stepping-down/ Portfolio Update LowYield MediumYield HighYield Week -2.02% -2.37% -3.52% Month +0.93% -0.82% -5.30% 2021 +15.52% +12.67% -11.50% Inception +36.50% +8.00% -11.70% Dividends Received this Week Amount (OKE) $109.40 (ARTNA) $60.29 (KMI) $305.91 Dividends…
-
J&J’s CEO announces he’s stepping down
Johnson & Johnson Chief Executive Alex Gorsky is stepping aside, handing over the reins to the world’s largest health-products company to a longtime lieutenant after nearly a decade at the helm. Mr. Gorsky, who is 61 years old, will become J&J’s executive chairman effective Jan. 3. Joaquin Duato, who had led J&J’s pharmaceuticals business before…
-
Johnson & Johnson post higher profit
The New Brunswick, N.J.-based company logged sales of $23.31 billion—a 27% increase year over year—and adjusted earnings of $2.48 a share. Wall Street analysts had forecast adjusted earnings of $2.29 a share and revenue of $22.49 billion, according to FactSet’s survey. Wall Street Journal